Go to the profile of Novadip


CEO, Novadip

About Novadip

Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip’s mission is to provide innovative solutions for patients with limited or no effective treatment options.

Therapeutic Areas

Stem Cell


Regenerative medicine

Company Type

Biotechnology – R&D services

State of Ownership


Sponsorship Group



Editions participated in:

June 2020